Prof. Kim Q. Do, the director of the Center for Psychiatric Neuroscience and head of the Unit for Research in Schizophrenia from Laussane has confirmed her visit to Neurogune
Prof. Do is a worldwide reference in translational neuroscience, for her interest in bridging basic neuroscience with problems of clinical psychiatry. She has a long and fruitful career, recognised and awarded several times, so it would be a pleasure to have the opportunity to listen to her this time.
The Spanish-Portuguese Meeting for Advanced Optical Microscopy strives to become the reference in bioimaging in Southern Europe
SPAOM (Spanish-Portuguese Meeting for Advanced Optical Microscopy) 2016 has its roots in the bi-annual meeting of the Spanish Network for Advanced Optical Microscopy (REMOA) and it is coorganised for the first time with the Portuguese Platform of BioImage.
SPAOM 2016 is a major scientific event that aims at promoting the Spanish and Portuguese bioimaging scientific community and fostering communication between scientists and industry. The conference has an international scope: focused on the national Spanish and Portuguese microscopic panorama it will also host invited talks by relevant european researchers and accept contributions from abroad.
This edition of SPAOM will take place in Bilbao, a lively city that combines tradition with modernity. Famous for its pintxo bars and restaurants, the city has become a cultural reference in Southern Europe. The event will be held at the Bizkaia Aretoa, one of the flagship buildings of the new Bilbao. The Bizkaia Aretoa is conveniently located at the heart of the city, within walking distance to the major hotels, to the Guggenheim Museum and the Old Quartier.
New funding for international collaborations between Centres of Excellence in neurodegenerative disease research
The Centres of Excellence in Neurodegenerative disease (CoEN) initiative, launched in 2010, funds collaborative research in the field of neurodegenerative disease, spanning age-related disorders such as Alzheimer's, Parkinson's and Motor Neuron Disease. Under the third CoEN funding call, £3.6m (€4.9m, CA$7.4m) has been awarded for 11 Pathfinder projects, constituting innovative and creative proof of principle studies which, if successful, will provide a step change in neurodegeneration research.
| The awarded projects take a ‘high risk, high pay-off' approach to identify and validate new potential drugs and develop innovative therapeutic approaches for Parkinson's Disease, Alzheimer's Disease and other dementias. These projects bring together a wealth of resources and expertise from a number of research centres of excellence in different countries to tackle scientific questions that are vital to advancement within the field. |
The Laboratory of Neurobiology of Achucarro and the UPV/EHU will be part of the network project entitled "Protection of neurons in vitro and in vivo from Synuclein toxicity by molecular tweezers", constituted and led by Erwan Bezard (Bordeaux, France), Carlos Matute (Bilbao, Spain) and Richard Wade-Martins (Oxford, UK).
Help lobby UNESCO for a World Heritage Listing
The newly formed Cajal Legacy Group is seeking your support to have the work of Ramon y Cajal and his school of talented protégées World Heritage Listed by UNESCO.
Santiago Ramón y Cajal (1852-1934) is unquestionably the founder of modern neuroscience and a genius in the field of biology. Cajal was the first person to describe the cellular structure of the brain and to link these networks of cells with the functioning of the mind.